Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

FHS
July 3, 2023
2:39 pm

Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Klebsiella: Emerging multidrug-resistant and hypervirulent threats to health

Announcing a new article publication for Zoonoses journal. Members of the genus, Klebsiella, are becoming increasingly challenging to control due to the recent convergence of

September 15, 2023

Cressey & Company Acquires HealthDrive – Health M&A

What You Should Know: Private equity investment firm Cressey & Company LP (“Cressey”) acquires HealthDrive, a leading multi-specialty clinical services organization to patients residing in

August 23, 2023

Akero’s treatment for NASH falls short in cirrhosis study

Akero Therapeutics said Tuesday that an experimental medicine failed to show a significant benefit for patients with cirrhosis caused by NASH, the most advanced and

October 10, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.